Europe Biotech Heavyweights Genmab And Argenx Ink Antibody Alliance
Starting With An Immunology And A Cancer Target
The two flagship firms of the European biotech scene are pooling their technologies to jointly discover, develop and commercialize drugs against cancer and autoimmune diseases.
